title: Phosphatases are emerging as novel druggable targets in Plasmodium.
authors.affiliation: Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019.
authors.forename: Jamal
authors.initials: J
authors.lastname: Khalife
authors.affiliation: UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000 Lille, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Pierrot
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000378:metabolism / Q000494:pharmacology*; D055808:Drug Discovery; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology; D010963:Plasmodium falciparum / Q000187:drug effects / Q000201:enzymology* / Q000502:physiology; D054645:Protein Phosphatase 1 / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D000962:Antimalarials; D054645:Protein Phosphatase 1
keywords: PP1 regulators; anti-malarials; drugs; phosphatases; plasmodium